ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
Dingxie Liu,
Qiongyu Hao,
Jieqing Li,
Qun Li,
Kun Wang,
Qing Geng,
Yutong Wu,
Jaydutt V. Vadgama,
Yong Wu
Affiliations
Dingxie Liu
Bluewater Biotech LLC New Providence NJ 07974 USA
Qiongyu Hao
Division of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USA
Jieqing Li
Division of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USA
Qun Li
Department of Oncology Shanghai East Hospital School of Medicine Tongji University Shanghai 200123 P. R. China
Kun Wang
Department of Breast Cancer Cancer Center Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences Guangzhou Guangdong 510080 P. R. China
Qing Geng
Department of Thoracic Surgery Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. China
Yutong Wu
Bluewater Biotech LLC New Providence NJ 07974 USA
Jaydutt V. Vadgama
Division of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USA
Yong Wu
Division of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USA
